Post-dilatation for Optimization of Drug-eluting Stents (DES) Deployment Assessed by Intravascular Ultrasound Multicenter Analysis
PODIUM
A Prospective Randomized Multicenter Study of the Efficacy and Safety of Systematic Post -Dilatation With Noncompliant Balloon After Successful Drug-eluting Stent Implantation. IVUS Analysis.
1 other identifier
interventional
220
1 country
1
Brief Summary
Comparison with use of Intravascular Ultrasound (IVUS) analysis of two methods of percutaneous coronary interventions (PCI) with drug eluting stent: After successful drug eluting stent implantation, patients were randomized into two groups: Group A had no further dilatation, and Group B had additional post-dilatation with a noncompliant balloon. The investigators performed IVUS analysis in groups A and B just before randomization and after post-dilatation in group B.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Apr 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2010
CompletedFirst Submitted
Initial submission to the registry
April 13, 2010
CompletedFirst Posted
Study publicly available on registry
April 15, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2011
CompletedJune 16, 2011
June 1, 2011
1.6 years
April 13, 2010
June 14, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Optimal stent deployment defined by IVUS analysis
The primary endpoint is optimum stent deployment. For defining the optimal stent deployment we use the IVUS criteria adopted in the MUSIC study: Complete apposition without underexpansion and with symmetric stent expansion. All patients(group A and B) will have IVUS analysis for defining optimal stent deployment
at 18 months
Secondary Outcomes (1)
Complications of percutaneous coronary intervention (PCI)
at day0, at day1, at the end of hospitalisation and year1
Study Arms (2)
classic strategy
PLACEBO COMPARATORafter drug-eluting stent(DES) deployment perform of Intravascular ultrasound analysis without post-dilatation
post-dilatation strategy
ACTIVE COMPARATORAfter drug-eluting stent (DES) deployment IVUS analysis and systematic post-dilatation with noncompliant balloon 0.25mm larger than stent balloon. After post dilatation new IVUS analysis.
Interventions
Post-dilatation with a noncompliant balloon larger 0.25mm than stent balloon.
stent deployment without systematic post dilatation
Eligibility Criteria
You may qualify if:
- Successful drug eluting stent implantation in a native coronary artery
You may not qualify if:
- Percutaneous coronary intervention (PCI) of Left main coronary artery;
- Myocardial infarction;
- Acute coronary syndrome;
- Emergency PCI;
- PCI for in-stent restenosis;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de cardiologie interventionnelle - Hôpital Lariboisière
Paris, 75010, France
Study Officials
- PRINCIPAL INVESTIGATOR
Georgios SIDERIS, MD
Assistance Publique - Hôpitaux de Paris
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- NETWORK
Study Record Dates
First Submitted
April 13, 2010
First Posted
April 15, 2010
Study Start
April 1, 2010
Primary Completion
November 1, 2011
Study Completion
November 1, 2011
Last Updated
June 16, 2011
Record last verified: 2011-06